Less Ads, More Data, More Tools Register for FREE

Pin to quick picksATK.L Regulatory News (ATK)

  • There is currently no data for ATK

Form 8.5 (EPT/RI) - WS Atkins Plc Amendment

6 Jun 2017 18:14

RNS Number : 3443H
JPMorgan Securities Plc
06 June 2017
 

AMENDMENT

INCREASED EQUITY SALES BY 36,885 TO 511,176

ADDED EQUITY SWAP PURCHASES OF 63,068

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-

SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

WS Atkins Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Financial Adviser & Corporate Broker to WS Atkins Plc

(d) Date dealing undertaken:

02 June 2017

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

(GBP)

 

Lowest price per unit paid/received

(GBP)

 

Ordinary Shares

 

Purchases

 

Sales

582,374

 

511,176

20.8600

 

20.8000

20.6800

 

20.7300

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(GBP)

Ordinary Shares

Equity Swaps

 

 

Long

 

 

 

 

 

Short

539

311

79

160

121

 

178

382

7

553

125,754

1,042

20.7285

20.7555

20.7584

20.7610

20.7992

 

20.7368

20.7416

20.7443

20.7694

20.8077

20.8194

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (GBP)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(GBP)

Ordinary Shares

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(GBP)

Ordinary Shares

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) (GBP)

 

 

 

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

06 June 2017

Contact name:

Tung Le

Telephone number:

020 7742 7272

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEREAXKKEFDXEFF
Date   Source Headline
20th Jul 20153:29 pmRNSDirector/PDMR Shareholding
15th Jul 20154:49 pmRNSHolding(s) in Company
26th Jun 20153:38 pmRNSDirector/PDMR Shareholding
26th Jun 20153:34 pmRNSDirector/PDMR Shareholding
25th Jun 20154:51 pmRNSAnnual Financial Report
22nd Jun 20155:01 pmRNSHolding(s) in Company
17th Jun 201512:04 pmRNSDirector/PDMR Shareholding
15th Jun 20155:53 pmRNSHolding(s) in Company
11th Jun 20157:00 amRNSFinal Results
10th Jun 20157:00 amRNSDirectorate Change
9th Jun 20152:00 pmRNSDirectorate Change
19th May 20152:13 pmRNSDirector/PDMR Shareholding
17th Apr 20151:39 pmRNSDirector/PDMR Shareholding
8th Apr 20157:00 amRNSTrading Statement
19th Mar 20157:00 amRNSAnalyst Presentation
18th Mar 20156:17 pmRNSDirector/PDMR Shareholding
18th Mar 20154:25 pmRNSDirector/PDMR Shareholding
18th Feb 20154:33 pmRNSDirector/PDMR Shareholding
18th Feb 20154:19 pmRNSDirector/PDMR Shareholding
11th Feb 20157:00 amRNSThird Quarter Trading Update
4th Feb 20155:27 pmRNSHolding(s) in Company
20th Jan 20154:48 pmRNSDirector/PDMR Shareholding
20th Jan 201512:20 pmRNSDirector Declaration
19th Jan 201510:06 amRNSDirector/PDMR Shareholding
15th Jan 20154:41 pmRNSDirector/PDMR Shareholding
12th Jan 20154:45 pmRNSDirector/PDMR Shareholding
6th Jan 20154:25 pmRNSDirector/PDMR Shareholding
17th Dec 20149:56 amRNSDirector/PDMR Shareholding
12th Dec 20143:50 pmRNSDirector/PDMR Shareholding
12th Dec 20141:49 pmRNSDirector/PDMR Shareholding
1st Dec 20144:26 pmRNSHolding(s) in Company
24th Nov 20144:16 pmRNSDirector/PDMR Shareholding
19th Nov 20144:31 pmRNSDirector/PDMR Shareholding
19th Nov 20144:14 pmRNSDirector/PDMR Shareholding
18th Nov 20144:07 pmRNSDirector/PDMR Shareholding
17th Nov 20145:18 pmRNSDirector/PDMR Shareholding
17th Nov 20145:03 pmRNSHolding(s) in Company
13th Nov 20147:00 amRNSHalf Yearly Report
7th Nov 20142:20 pmRNSHolding(s) in Company
6th Nov 20142:27 pmRNSHolding(s) in Company
16th Oct 20143:35 pmRNSDirector/PDMR Shareholding
2nd Oct 20147:00 amRNSAnalyst Presentation
1st Oct 20147:00 amRNSAcquisition
29th Sep 20144:12 pmRNSDirector/PDMR Shareholding
26th Sep 20145:01 pmRNSHolding(s) in Company
26th Sep 20142:15 pmRNSHolding(s) in Company
25th Sep 20147:00 amRNSTrading Statement
17th Sep 20144:30 pmRNSDirector/PDMR Shareholding
12th Sep 201411:01 amRNSHolding(s) in Company
8th Sep 20147:00 amRNSAtkins acquires US based nuclear business

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.